wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42315543-D46D6821-8C6F-482D-A1AA-7027F8A2A5F8
Q42315543-D46D6821-8C6F-482D-A1AA-7027F8A2A5F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42315543-D46D6821-8C6F-482D-A1AA-7027F8A2A5F8
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.
P2860
Q42315543-D46D6821-8C6F-482D-A1AA-7027F8A2A5F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42315543-D46D6821-8C6F-482D-A1AA-7027F8A2A5F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d668e5475b5bea627aea43550e311fa1bc4dbe5
P2860
Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.